Hypothalamo-Hypophyseal System
"Hypothalamo-Hypophyseal System" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.
| Descriptor ID |
D007030
|
| MeSH Number(s) |
A06.688.357 A08.186.211.464.497.352.435 A08.186.211.730.317.357.352.435 A08.713.357
|
| Concept/Terms |
Hypothalamo-Hypophyseal System- Hypothalamo-Hypophyseal System
- Hypothalamo Hypophyseal System
- Hypothalamic-Pituitary Unit
- Hypothalamic Pituitary Unit
- Hypophyseal Portal System
- Portal System, Hypophyseal
|
Below are MeSH descriptors whose meaning is more general than "Hypothalamo-Hypophyseal System".
Below are MeSH descriptors whose meaning is more specific than "Hypothalamo-Hypophyseal System".
This graph shows the total number of publications written about "Hypothalamo-Hypophyseal System" by people in this website by year, and whether "Hypothalamo-Hypophyseal System" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypothalamo-Hypophyseal System" by people in Profiles.
-
Amin M, Horst N, Wu R, Gragnoli C. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome. J Ovarian Res. 2023 Aug 05; 16(1):155.
-
Amin M, Syed S, Wu R, Postolache TT, Gragnoli C. Familial Linkage and Association of the NR3C1 Gene with Type 2 Diabetes and Depression Comorbidity. Int J Mol Sci. 2022 Oct 08; 23(19).
-
Amin M, Ott J, Wu R, Postolache TT, Gragnoli C. Implication of Melanocortin Receptor Genes in the Familial Comorbidity of Type 2 Diabetes and Depression. Int J Mol Sci. 2022 Jul 28; 23(15).
-
Rieder JK, Kleshchova O, Weierich MR. Estradiol, stress reactivity, and daily affective experiences in trauma-exposed women. Psychol Trauma. 2022 Jul; 14(5):738-746.
-
Rieder JK, Goshin LS, Sissoko DRG, Kleshchova O, Weierich MR. Salivary Biomarkers of Parenting Stress in Mothers Under Community Criminal Justice Supervision. Nurs Res. 2019 Jan/Feb; 68(1):48-56.
-
Kleshchova O, Rieder JK, Grinband J, Weierich MR. Resting amygdala connectivity and basal sympathetic tone as markers of chronic hypervigilance. Psychoneuroendocrinology. 2019 04; 102:68-78.
-
Peters AT, Smith RA, Kassel MT, Hagan M, Maki P, Van Meter A, Brice?o EM, Ryan KA, Weldon AL, Weisenbach SL, Starkman MN, Langenecker SA. A pilot investigation of differential neuroendocrine associations with fronto-limbic activation during semantically-cued list learning in mood disorders. J Affect Disord. 2018 10 15; 239:180-191.
-
Prossin AR, Chandler M, Ryan KA, Saunders EF, Kamali M, Papadopoulos V, Z?llner S, Dantzer R, McInnis MG. Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorder. Psychoneuroendocrinology. 2018 03; 89:194-202.
-
Skoner DP, Berger WE, Gawchik SM, Akbary A, Qiu C. Intranasal triamcinolone and growth velocity. Pediatrics. 2015 Feb; 135(2):e348-56.
-
Lee PA, Klein K, Mauras N, Lev-Vaisler T, Bacher P. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty. J Clin Endocrinol Metab. 2014 Sep; 99(9):3153-9.